637 related articles for article (PubMed ID: 18772941)
1. Prevalence of rectal carriage of extended-spectrum beta-lactamase-producing Escherichia coli among elderly people in community settings in China.
Tian SF; Chen BY; Chu YZ; Wang S
Can J Microbiol; 2008 Sep; 54(9):781-5. PubMed ID: 18772941
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases.
Calbo E; Romaní V; Xercavins M; Gómez L; Vidal CG; Quintana S; Vila J; Garau J
J Antimicrob Chemother; 2006 Apr; 57(4):780-3. PubMed ID: 16492721
[TBL] [Abstract][Full Text] [Related]
3. Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals.
Peirano G; Costello M; Pitout JD
Int J Antimicrob Agents; 2010 Jul; 36(1):19-23. PubMed ID: 20359869
[TBL] [Abstract][Full Text] [Related]
4. Escherichia coli producing SHV-type extended-spectrum beta-lactamase is a significant cause of community-acquired infection.
Rodríguez-Baño J; Alcalá J; Cisneros JM; Grill F; Oliver A; Horcajada JP; Tórtola T; Mirelis B; Navarro G; Cuenca M; Esteve M; Peña C; Llanos AC; Cantón R; Pascual A
J Antimicrob Chemother; 2009 Apr; 63(4):781-4. PubMed ID: 19223299
[TBL] [Abstract][Full Text] [Related]
5. Community emergence of CTX-M type extended-spectrum beta-lactamases among urinary Escherichia coli from women.
Ho PL; Poon WW; Loke SL; Leung MS; Chow KH; Wong RC; Yip KS; Lai EL; Tsang KW;
J Antimicrob Chemother; 2007 Jul; 60(1):140-4. PubMed ID: 17496058
[TBL] [Abstract][Full Text] [Related]
6. Faecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology.
Rodríguez-Baño J; López-Cerero L; Navarro MD; Díaz de Alba P; Pascual A
J Antimicrob Chemother; 2008 Nov; 62(5):1142-9. PubMed ID: 18641033
[TBL] [Abstract][Full Text] [Related]
7. Clinical and molecular epidemiology of community-onset, extended-spectrum beta-lactamase-producing Escherichia coli infections in Thailand: a case-case-control study.
Apisarnthanarak A; Kiratisin P; Saifon P; Kitphati R; Dejsirilert S; Mundy LM
Am J Infect Control; 2007 Nov; 35(9):606-12. PubMed ID: 17980240
[TBL] [Abstract][Full Text] [Related]
8. Molecular epidemiology of Escherichia coli producing extended-spectrum {beta}-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15.
Blanco M; Alonso MP; Nicolas-Chanoine MH; Dahbi G; Mora A; Blanco JE; López C; Cortés P; Llagostera M; Leflon-Guibout V; Puentes B; Mamani R; Herrera A; Coira MA; García-Garrote F; Pita JM; Blanco J
J Antimicrob Chemother; 2009 Jun; 63(6):1135-41. PubMed ID: 19351692
[TBL] [Abstract][Full Text] [Related]
9. ISEcp1 element in association with bla(CTX-M) genes of E. coli that produce extended-spectrum β-lactamase among the elderly in community settings.
Tian SF; Chu YZ; Chen BY; Nian H; Shang H
Enferm Infecc Microbiol Clin; 2011 Dec; 29(10):731-4. PubMed ID: 22019175
[TBL] [Abstract][Full Text] [Related]
10. Detection of CTX-M-15, CTX-M-22, and SHV-2 extended-spectrum beta-lactamases (ESBLs) in Escherichia coli fecal-sample isolates from pig farms in China.
Tian GB; Wang HN; Zou LK; Tang JN; Zhao YW; Ye MY; Tang JY; Zhang Y; Zhang AY; Yang X; Xu CW; Fu YJ
Foodborne Pathog Dis; 2009 Apr; 6(3):297-304. PubMed ID: 19272004
[TBL] [Abstract][Full Text] [Related]
11. Clinical and molecular epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli as a cause of nosocomial infection or colonization: implications for control.
Rodríguez-Baño J; Navarro MD; Romero L; Muniain MA; Perea EJ; Pérez-Cano R; Hernández JR; Pascual A
Clin Infect Dis; 2006 Jan; 42(1):37-45. PubMed ID: 16323089
[TBL] [Abstract][Full Text] [Related]
12. CTX-M-producing Escherichia coli in a maternity ward: a likely community importation and evidence of mother-to-neonate transmission.
Dubois V; De Barbeyrac B; Rogues AM; Arpin C; Coulange L; Andre C; M'zali F; Megraud F; Quentin C
J Antimicrob Chemother; 2010 Jul; 65(7):1368-71. PubMed ID: 20466850
[TBL] [Abstract][Full Text] [Related]
13. Molecular epidemiology of multiresistant Escherichia coli isolates from community-onset urinary tract infections in Cornwall, England.
Woodford N; Kaufmann ME; Karisik E; Hartley JW
J Antimicrob Chemother; 2007 Jan; 59(1):106-9. PubMed ID: 17090553
[TBL] [Abstract][Full Text] [Related]
14. Emergence and dissemination of extended-spectrum beta-lactamase-producing Escherichia coli in the community: lessons from the study of a remote and controlled population.
Woerther PL; Angebault C; Lescat M; Ruppé E; Skurnik D; Mniai AE; Clermont O; Jacquier H; Costa AD; Renard M; Bettinger RM; Epelboin L; Dupont C; Guillemot D; Rousset F; Arlet G; Denamur E; Djossou F; Andremont A
J Infect Dis; 2010 Aug; 202(4):515-23. PubMed ID: 20617925
[TBL] [Abstract][Full Text] [Related]
15. Evolution of CTX-M-type beta-lactamases in isolates of Escherichia coli infecting hospital and community patients.
Brigante G; Luzzaro F; Perilli M; Lombardi G; Colì A; Rossolini GM; Amicosante G; Toniolo A
Int J Antimicrob Agents; 2005 Feb; 25(2):157-62. PubMed ID: 15664486
[TBL] [Abstract][Full Text] [Related]
16. First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system.
Lewis JS; Herrera M; Wickes B; Patterson JE; Jorgensen JH
Antimicrob Agents Chemother; 2007 Nov; 51(11):4015-21. PubMed ID: 17724160
[TBL] [Abstract][Full Text] [Related]
17. Turkey: a further country concerned by community-acquired Escherichia coli clone O25-ST131 producing CTX-M-15.
Yumuk Z; Afacan G; Nicolas-Chanoine MH; Sotto A; Lavigne JP
J Antimicrob Chemother; 2008 Aug; 62(2):284-8. PubMed ID: 18453527
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and types of extended-spectrum beta-lactamases among urinary Escherichia coli and Klebsiella spp. in New Zealand.
Heffernan HM; Woodhouse RE; Pope CE; Blackmore TK
Int J Antimicrob Agents; 2009 Dec; 34(6):544-9. PubMed ID: 19748232
[TBL] [Abstract][Full Text] [Related]
19. Community-onset bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: risk factors and prognosis.
Rodríguez-Baño J; Picón E; Gijón P; Hernández JR; Ruíz M; Peña C; Almela M; Almirante B; Grill F; Colomina J; Giménez M; Oliver A; Horcajada JP; Navarro G; Coloma A; Pascual A;
Clin Infect Dis; 2010 Jan; 50(1):40-8. PubMed ID: 19995215
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of infections caused by extended-spectrum β-lactamase-producing Escherichia coli from community hospitals in South Africa.
Peirano G; van Greune CH; Pitout JD
Diagn Microbiol Infect Dis; 2011 Apr; 69(4):449-53. PubMed ID: 21396544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
